T1	PROC 1 43	Estudio prospectivo, doble ciego y cruzado
#1	AnnotatorNotes T1	C0033522; Prospective Studies; Research Activity + C0013072; Double-Blind Method; Research Activity + C0010362; Cross-Sectional Studies; Research Activity
T2	DISO 86 99	dislipidemias
#2	AnnotatorNotes T2	C0242339; Dyslipidemias; Disease or Syndrome
T3	PROC 113 137	Estudios epidemiológicos
#3	AnnotatorNotes T3	C0002783; Epidemiologic Studies; Research Activity
T4	DISO 189 203	aterosclerosis
#4	AnnotatorNotes T4	C0004153; Atherosclerosis; Disease or Syndrome
T5	PROC 208 227	terapia nutricional
#5	AnnotatorNotes T5	C2937349; Nutrition Therapy; Health Care Activity
T6	PROC 254 275	estrategia preventiva
T7	PROC 655 670	Se randomizaron
#6	AnnotatorNotes T7	C0034656; Randomization; Research Activity
T8	DISO 450 463	dislipidemias
#7	AnnotatorNotes T8	C0242339; Dyslipidemias; Disease or Syndrome
T9	CHEM 578 583	graso
#8	AnnotatorNotes T9	C0015677; Fatty acid glycerol esters; Organic Chemical · Pharmacologic Substance
T10	CHEM 634 644	colesterol
#9	AnnotatorNotes T10	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T11	PROC 680 705	tratamientos secuenciales
#10	AnnotatorNotes T11	C1519252; Sequential Treatment; Therapeutic or Preventive Procedure
T12	DISO 328 354	enfermedad aterosclerótica
#11	AnnotatorNotes T12	C0004153; Atherosclerosis; Disease or Syndrome
T13	CHEM 737 763	extracto seco del té verde
#12	AnnotatorNotes T13	C0937627; GREEN TEA LEAF EXTRACT; Organic Chemical · Pharmacologic Substance
T14	PROC 766 773	placebo
#13	AnnotatorNotes T14	C0032042; Placebos; Therapeutic or Preventive Procedure
T15	PROC 906 913	placebo
#14	AnnotatorNotes T15	C0032042; Placebos; Therapeutic or Preventive Procedure
T16	PROC 949 966	valores lipídicos
#15	AnnotatorNotes T16	C0523744; Lipids measurement; Laboratory Procedure
T17	CHEM 957 966	lipídicos
#16	AnnotatorNotes T17	C0023779; Lipids; Organic Chemical
T18	CHEM 1033 1043	colesterol
#17	AnnotatorNotes T18	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T19	PROC 1156 1165	lipídicas
#18	AnnotatorNotes T19	C0523744; Lipids measurement; Laboratory Procedure
T20	CHEM 1311 1321	colesterol
#19	AnnotatorNotes T20	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T22	PROC 1562 1598	evaluación de los lípidos sanguíneos
T23	PROC 1120 1125	Apo-B
#20	AnnotatorNotes T23	C0523509; Apolipoprotein B Assay; Laboratory Procedure
T24	CHEM 1600 1610	colesterol
#21	AnnotatorNotes T24	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T25	PROC 1653 1660	placebo
#22	AnnotatorNotes T25	C0032042; Placebos; Therapeutic or Preventive Procedure
T26	CHEM 1804 1814	colesterol
#23	AnnotatorNotes T26	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T27	DISO 173 186	dislipidemias
#24	AnnotatorNotes T27	C0242339; Dyslipidemias; Disease or Syndrome
T28	PROC 557 583	dieta con bajo tenor graso
#25	AnnotatorNotes T28	C0242970; Fat-Restricted Diet; Therapeutic or Preventive Procedure
T29	PROC 1006 1020	HDL-colesterol
#26	AnnotatorNotes T29	C0392885; High density lipoprotein measurement; Laboratory Procedure
T30	PROC 1033 1049	colesterol total
#27	AnnotatorNotes T30	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T31	PROC 1062 1076	LDL-colesterol
#28	AnnotatorNotes T31	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T32	PROC 1091 1104	triglicéridos
#29	AnnotatorNotes T32	C0202236; Triglycerides measurement; Laboratory Procedure
T33	PROC 1291 1327	concentraciones del colesterol total
#30	AnnotatorNotes T33	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T34	PROC 1372 1386	LDL-colesterol
#31	AnnotatorNotes T34	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T35	PROC 1450 1475	niveles de HDL-colesterol
#32	AnnotatorNotes T35	C0392885; High density lipoprotein measurement; Laboratory Procedure
T36	PROC 1484 1497	triglicéridos
#33	AnnotatorNotes T36	C0202236; Triglycerides measurement; Laboratory Procedure
T37	CHEM 1580 1587	lípidos
#34	AnnotatorNotes T37	C0023779; Lipids; Organic Chemical
T38	ANAT 1588 1598	sanguíneos
#35	AnnotatorNotes T38	C0005767; Blood; Body Substance
T39	PROC 1600 1616	colesterol total
#36	AnnotatorNotes T39	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T40	PROC 1619 1633	LDL-colesterol
#37	AnnotatorNotes T40	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T41	PROC 1793 1820	niveles de colesterol total
#38	AnnotatorNotes T41	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T42	PROC 1823 1837	LDL-colesterol
#39	AnnotatorNotes T42	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T43	LIVB 279 289	individuos
#40	AnnotatorNotes T43	C0027361; Persons; Population Group
T44	Spec_cue 316 322	riesgo
T45	LIVB 426 435	pacientes
#41	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 499 508	pacientes
#42	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Age 519 537	entre 21 y 71 años
T49	Dose 625 630	200mg
T50	Frequency 645 652	por día
T51	Form 707 715	cápsulas
#43	AnnotatorNotes T51	C4722245; Capsule Dose Form Category; Functional Concept
T52	Dose 728 733	250mg
T53	Duration 813 823	16 semanas
T54	LIVB 839 847	paciente
#44	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 891 903	ocho semanas
T58	Duration 1775 1787	ocho semanas
T59	LIVB 1854 1863	pacientes
#45	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 69 77	té verde
#46	AnnotatorNotes T60	C0949852; Camellia sinensis; Plant
T62	LIVB 394 402	té verde
#47	AnnotatorNotes T62	C0949852; Camellia sinensis; Plant
T63	LIVB 755 763	té verde
#48	AnnotatorNotes T63	C0949852; Camellia sinensis; Plant
T64	LIVB 858 866	té verde
#49	AnnotatorNotes T64	C0949852; Camellia sinensis; Plant
T66	LIVB 1203 1211	té verde
#50	AnnotatorNotes T66	C0949852; Camellia sinensis; Plant
T67	LIVB 1404 1412	té verde
#51	AnnotatorNotes T67	C0949852; Camellia sinensis; Plant
T69	LIVB 1711 1719	té verde
#52	AnnotatorNotes T69	C0949852; Camellia sinensis; Plant
T70	LIVB 50 67	Camellia sinensis
#53	AnnotatorNotes T70	C0949852; Camellia sinensis; Plant
T61	LIVB 404 421	Camellia sinensis
#54	AnnotatorNotes T61	C0949852; Camellia sinensis; Plant
T48	LIVB 868 885	Camellia sinensis
#55	AnnotatorNotes T48	C0949852; Camellia sinensis; Plant
T71	LIVB 1213 1230	Camellia sinensis
#56	AnnotatorNotes T71	C0949852; Camellia sinensis; Plant
T56	LIVB 1721 1738	Camellia sinensis
#57	AnnotatorNotes T56	C0949852; Camellia sinensis; Plant
T21	PROC 1506 1511	Apo-B
#58	AnnotatorNotes T21	C0523509; Apolipoprotein B Assay; Laboratory Procedure
A1	Assertion T12 Speculated
T57	CONC 1416 1426	influenció
A2	Assertion T57 Negated
#59	AnnotatorNotes T57	C4054723; Influence; Conceptual Entity
T65	Neg_cue 1413 1415	no
R1	Negation Arg1:T65 Arg2:T57	
T68	Neg_cue 1524 1526	no
T72	Quantifier_or_Qualifier 1527 1541	significativos
A3	Assertion T72 Negated
#60	AnnotatorNotes T72	C0750502; Significant; Idea or Concept
R2	Negation Arg1:T68 Arg2:T72	
R3	Overlap Arg1:T27 Arg2:T4	
R4	Experiences Arg1:T43 Arg2:T5	
R5	Speculation Arg1:T44 Arg2:T12	
R6	Experiences Arg1:T43 Arg2:T12	
T73	Observation 304 322	factores de riesgo
#61	AnnotatorNotes T73	C0035648; risk factors; Finding
R7	Experiences Arg1:T43 Arg2:T73	
R8	Experiences Arg1:T45 Arg2:T8	
R9	Experiences Arg1:T46 Arg2:T28	
R10	Has_Age Arg1:T46 Arg2:T47	
R11	Has_Dose_or_Strength Arg1:T10 Arg2:T49	
R12	Has_Frequency Arg1:T10 Arg2:T50	
R13	Before Arg1:T7 Arg2:T11	
R14	Has_Drug_Form Arg1:T13 Arg2:T51	
R15	Has_Dose_or_Strength Arg1:T13 Arg2:T52	
R16	Before Arg1:T7 Arg2:T13	
R17	Before Arg1:T7 Arg2:T14	
R18	Has_Duration_or_Interval Arg1:T14 Arg2:T55	
R19	Has_Duration_or_Interval Arg1:T13 Arg2:T55	
R20	Experiences Arg1:T54 Arg2:T11	
R21	Experiences Arg1:T54 Arg2:T13	
R22	Experiences Arg1:T54 Arg2:T14	
R23	Has_Duration_or_Interval Arg1:T64 Arg2:T55	
R24	Has_Duration_or_Interval Arg1:T48 Arg2:T55	
R25	Experiences Arg1:T54 Arg2:T15	
R26	Experiences Arg1:T54 Arg2:T64	
R27	Experiences Arg1:T54 Arg2:T48	
R28	Has_Duration_or_Interval Arg1:T15 Arg2:T55	
T74	Quantifier_or_Qualifier 967 974	basales
#62	AnnotatorNotes T74	C1442488; Baseline; Quantitative Concept
R29	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T74	
T76	Observation 1250 1259;1284 1327	reducción en las concentraciones del colesterol total
#63	AnnotatorNotes T76	C0860921; Cholesterol total decreased; Finding
T77	Observation 1334 1343;1368 1386	reducción del LDL-colesterol
#64	AnnotatorNotes T77	C5232976; Reduced low-density lipoprotein cholesterol (LDL-C); Finding
R32	Causes Arg1:T66 Arg2:T76	
R33	Causes Arg1:T66 Arg2:T77	
R34	Causes Arg1:T71 Arg2:T77	
R35	Causes Arg1:T71 Arg2:T76	
T75	PHYS 1391 1400	ingestión
#65	AnnotatorNotes T75	C0232478; Ingestion; Biologic Function
R30	Used_for Arg1:T67 Arg2:T75	
T78	Quantifier_or_Qualifier 1427 1445	significativamente
A4	Assertion T78 Negated
#66	AnnotatorNotes T78	C0237881; Statistical Significance; Quantitative Concept
R36	Negation Arg1:T65 Arg2:T78	
R37	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T78	
R41	Location_of Arg1:T38 Arg2:T22	
R42	Location_of Arg1:T38 Arg2:T39	
R43	Location_of Arg1:T38 Arg2:T40	
T79	Observation 1691 1706	efecto benéfico
R47	Causes Arg1:T69 Arg2:T79	
R48	Causes Arg1:T56 Arg2:T79	
T80	Observation 1745 1751;1793 1820	redujo niveles de colesterol total
#67	AnnotatorNotes T80	C0860921; Cholesterol total decreased; Finding
R52	Causes Arg1:T56 Arg2:T80	
R53	Causes Arg1:T69 Arg2:T80	
T81	Observation 1745 1751;1823 1837	redujo LDL-colesterol
#68	AnnotatorNotes T81	C5232976; Reduced low-density lipoprotein cholesterol (LDL-C); Finding
R54	Causes Arg1:T56 Arg2:T81	
R55	Causes Arg1:T69 Arg2:T81	
R56	Experiences Arg1:T59 Arg2:T79	
R57	Experiences Arg1:T59 Arg2:T81	
R58	Experiences Arg1:T59 Arg2:T42	
R59	Experiences Arg1:T59 Arg2:T41	
R60	Experiences Arg1:T59 Arg2:T80	
R61	Has_Duration_or_Interval Arg1:T80 Arg2:T58	
R62	Has_Duration_or_Interval Arg1:T81 Arg2:T58	
R63	Experiences Arg1:T59 Arg2:T69	
R64	Experiences Arg1:T59 Arg2:T56	
R65	Experiences Arg1:T45 Arg2:T61	
R66	Experiences Arg1:T45 Arg2:T62	
R67	Has_Duration_or_Interval Arg1:T11 Arg2:T53	
R68	Experiences Arg1:T46 Arg2:T10	
R69	Has_Dose_or_Strength Arg1:T14 Arg2:T52	
R70	Has_Drug_Form Arg1:T14 Arg2:T51	
R71	Has_Drug_Form Arg1:T15 Arg2:T51	
R72	Has_Dose_or_Strength Arg1:T15 Arg2:T52	
T82	CONC 1513 1523	Resultados
#69	AnnotatorNotes T82	C1274040; Result; Functional Concept
R31	Has_Quantifier_or_Qualifier Arg1:T82 Arg2:T72	
#70	AnnotatorNotes T79	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#71	AnnotatorNotes T22	C0200382; Lipid panel; Laboratory Procedure (?)
A5	Experiencer T43 Patient
A6	Experiencer T45 Patient
A7	Experiencer T46 Patient
A8	Experiencer T54 Patient
A9	Experiencer T59 Patient
R38	Has_Result_or_Value Arg1:T33 Arg2:T76	
R39	Has_Result_or_Value Arg1:T34 Arg2:T77	
R40	Has_Result_or_Value Arg1:T41 Arg2:T80	
R44	Has_Result_or_Value Arg1:T42 Arg2:T81	
